Please login to the form below

Not currently logged in


This page shows the latest Brilinta news and features for those working in and with pharma, biotech and healthcare.

AZ reports growth again in Q3, driven by oncology and China sales

AZ reports growth again in Q3, driven by oncology and China sales

Its cardiovascular, renal and metabolism (CVRM) franchise was also up 11% to $1.1bn, with growth in sales of Brilinta and Farxiga paving the way.

Latest news

More from news
Approximately 11 fully matching, plus 36 partially matching documents found.

Latest from PMHub

  • Maker Projects

    Our clients include: The NHS NWEH Cancer Research Cosentyx / Novartis Brilinta / AstraZeneca Port of Call We have branches in Manchester and London - to find out more:

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...